Ado-trastuzumab emtansine Intravenous and Dextran 40
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Dextran 40 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: dextran, low molecular weight
Brand name: LMD
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Dextran 70 6% in 5% Dextrose high molecular weight
- Ado-trastuzumab emtansine Intravenous-Dextran 75
- Ado-trastuzumab emtansine Intravenous-Dextran high molecular weight
- Ado-trastuzumab emtansine Intravenous-Dextranomer and Hyaluronate Derivatives (Deflux)
- Ado-trastuzumab emtansine Intravenous-Dextranomer and Hyaluronate Derivatives (Solesta)
- Ado-trastuzumab emtansine Intravenous-Dextranomer and sodium hyaluronate
- Dextran 40-Adox Pak 2/100
- Dextran 40-Adoxa
- Dextran 40-Adoxa CK
- Dextran 40-Adoxa Pak
- Dextran 40-Adoxa Pak 1/100
- Dextran 40-Adoxa Pak 1/150